MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/ard-2021-221925

Медицинская библиотека · Annals of the rheumatic diseases · 2022

Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.

Adamska Julia Z, Zia Amin, Bloom Michelle S, Crofford Leslie J, Furst Daniel E, Goldmuntz Ellen, Keyes-Elstein Lynette, Mayes Maureen D, McSweeney Peter, Nash Richard A, Pinckney Ashley, Welch Beverly, Love Zelda Z, Sullivan Keith M, Robinson William

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

OBJECTIVES

Myeloablative autologous haematopoietic stem cell transplant (HSCT) was recently demonstrated to provide significant benefit over cyclophosphamide (CYC) in the treatment of diffuse cutaneous systemic sclerosis (dcSSc) in the Scleroderma: Cyclophosphamide or Transplantation (SCOT) trial. As dysregulation of the B cell compartment has previously been described in dcSSc, we sought to gain insight into the effects of myeloablative autologous HSCT as compared with CYC.

METHODS

We sequenced the peripheral blood immunoglobulin heavy chain (IGH) repertoires in patients with dcSSc enrolled in the SCOT trial.

RESULTS

Myeloablative autologous HSCT was associated with a sustained increase in IgM isotype antibodies bearing a low mutation rate. Clonal expression was reduced in IGH repertoires following myeloablative autologous HSCT. Additionally, we identified a underusage of immunoglobulin heavy chain V gene 5-51 in patients with dcSSc, and usage normalised following myeloablative autologous HSCT but not CYC treatment.

CONCLUSIONS

Together, these findings suggest that myeloablative autologous HSCT resets the IGH repertoire to a more naïve state characterised by IgM-expressing B cells, providing a possible mechanism for the elimination of pathogenic B cells that may contribute to the benefit of HSCT over CYC in the treatment of dcSSc.

Для цитирования: Adamska Julia Z, Zia Amin, Bloom Michelle S, Crofford Leslie J, Furst Daniel E, Goldmuntz Ellen, Keyes-Elstein Lynette, Mayes Maureen D, McSweeney Peter, Nash Richard A, Pinckney Ashley, Welch Beverly, Love Zelda Z, Sullivan Keith M, Robinson William. Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.. Annals of the rheumatic diseases. 2022. DOI: 10.1136/ard-2021-221925.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.